HIV-v: Phase Ib/II data

A U.K. Phase Ib/II trial in 55 HIV-positive patients who have not yet required antiretroviral therapy showed that a single subcutaneous injection of Seek's high-dose HIV-v vaccine with adjuvant reduce...